Literature DB >> 22706173

Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review.

Hiromichi Ishiyama1, Takahiro Hirayama, Pavan Jhaveri, Takefumi Satoh, Arnold C Paulino, Bo Xu, Edward Brian Butler, Bin S Teh.   

Abstract

PURPOSE: Transurethral resection of the prostate (TURP) is considered by some as a risk factor for genitourinary (GU) toxicity after radiotherapy (RT). However, there are conflicting results regarding the interaction between RT and TURP with respect to GU toxicity. The purpose of this report is to review the published data concerning TURP before or after RT and its effect on urinary complication. METHODS AND MATERIALS: A systematic literature review based on database searches in MEDLINE, EMBASE, Pubmed, Ovid, and Chochrane Library. The eligibility criteria of final review were (1) definitive RT for prostate cancer is reported; (2) comparison of GU toxicities between patients with and without TURP is reported; (3) minimum 5 patients after TURP are included.
RESULTS: Twelve articles regarding overall GU toxicity, 15 articles regarding urinary incontinence, and 13 articles regarding urinary or bladder neck stricture met eligibility criteria, and they were included in the final review. A quantitative synthesis from the data of selected articles was impossible because of variable grading systems and variable definitions in their comparisons between patients with and without TURP. However, most published articles demonstrated the increased risk of GU toxicity with TURP in patients treated with RT.
CONCLUSIONS: Our systematic review strongly suggests that TURP is one of the risk factors of GU toxicity after RT. This needs to be taken seriously when prostate cancer patients with TURP are considered for RT either external beam or brachytherapy.

Entities:  

Mesh:

Year:  2014        PMID: 22706173     DOI: 10.1097/COC.0b013e3182546821

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  11 in total

Review 1.  [Pathogenesis of urological complications after radiation therapy].

Authors:  Y Tolkach; G Kristiansen
Journal:  Urologe A       Date:  2017-03       Impact factor: 0.639

2.  [Urethral stricture rate after prostate cancer radiotherapy : Five-year data of a certified prostate cancer center].

Authors:  J Kranz; G Maurer; U Maurer; O Deserno; S Schulte; J Steffens
Journal:  Urologe A       Date:  2017-03       Impact factor: 0.639

3.  SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial.

Authors:  Raquibul Hannan; Samer Salamekh; Neil B Desai; Aurelie Garant; Michael R Folkert; Daniel N Costa; Samantha Mannala; Chul Ahn; Osama Mohamad; Aaron Laine; Dong W Nathan Kim; Tamara Dickinson; Ganesh V Raj; Rajal B Shah; Jing Wang; Xun Jia; Hak Choy; Claus G Roehrborn; Yair Lotan; Robert D Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-11-11       Impact factor: 8.013

4.  Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.

Authors:  Marie K Gurka; Leonard N Chen; Aditi Bhagat; Rudy Moures; Joy S Kim; Thomas Yung; Siyuan Lei; Brian T Collins; Pranay Krishnan; Simeng Suy; Anatoly Dritschilo; John H Lynch; Sean P Collins
Journal:  Radiat Oncol       Date:  2015-02-19       Impact factor: 3.481

5.  Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP).

Authors:  Abigail Pepin; Nima Aghdam; Sarthak Shah; Shaan Kataria; Harry Tsou; Subhradeep Datta; Malika Danner; Marilyn Ayoob; Thomas Yung; Siyuan Lei; Marie Gurka; Brian T Collins; Pranay Krishnan; Simeng Suy; Ryan Hankins; John H Lynch; Sean P Collins
Journal:  Front Oncol       Date:  2020-05-05       Impact factor: 6.244

6.  Transurethral Prostatectomy Before or After External Beam Radiotherapy: Complications and Reoperation Rates.

Authors:  Gabriel Molineros; Amichay Meirovitz; Marc Wygoda; Mohammad Zuaiter; Vladimir Yutkin; Mordechai Duvdevani; Guy Hidas; Ofer N Gofrit
Journal:  Res Rep Urol       Date:  2021-04-19

7.  Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.

Authors:  Leonard N Chen; Simeng Suy; Hongkun Wang; Aditi Bhagat; Jennifer A Woo; Rudy A Moures; Joy S Kim; Thomas M Yung; Siyuan Lei; Brian T Collins; Keith Kowalczyk; Anatoly Dritschilo; John H Lynch; Sean P Collins
Journal:  Radiat Oncol       Date:  2014-06-26       Impact factor: 3.481

8.  Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia.

Authors:  Mélanie Guilhen; Christophe Hennequin; Idir Ouzaid; Ingrid Fumagalli; Valentine Martin; Sophie Guillerm; Pierre Mongiat-Artus; Vincent Ravery; François Desgrandchamps; Laurent Quéro
Journal:  Radiat Oncol       Date:  2018-10-24       Impact factor: 3.481

Review 9.  Urological complications after radiation therapy-nothing ventured, nothing gained: a Narrative Review.

Authors:  Joanna Chorbińska; Wojciech Krajewski; Romuald Zdrojowy
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

Review 10.  High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome.

Authors:  Iosif Strouthos; Efstratios Karagiannis; Nikolaos Zamboglou; Konstantinos Ferentinos
Journal:  Cancer Rep (Hoboken)       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.